• Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively license Adaptimmune’s TCR T-cell therapy candidate, uza-cel, in head & neck cancer and potential future solid tumor indications

    Friday May 31st 2024

  • reMYND announces publication in Science of novel drug target with potential for development into transformative treatments for Alzheimer’s disease

    Thursday May 30th 2024

  • Waste2Func Video Release: The technology is ready, are we?

    Friday May 24th 2024

  • BIO INX and Readily3D Announce Collaboration to Advance Volumetric Bioprinting with Cutting-edge Gel-MA Based Ink

    Wednesday May 22nd 2024

  • Sequana Medical announces positive outcome of Day 100 meeting with FDA regarding PMA application for alfapump®

    Wednesday May 22nd 2024

  • Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S.

    Friday May 17th 2024

  • 20 years of progress: flanders.bio and VIB put biotech and life sciences in spotlight

    Wednesday May 15th 2024

  • Mithra announces grant of two additional U.S. patents for NEXTSTELLIS®

    Monday May 13th 2024

  • Your news here?

  • Important Advances in Oxurion's R&D Program on Geographic Atrophy secondary to AMD

    Tuesday May 7th 2024

  • KU Leuven Secures $2.8 Million Grant to Investigate Origins of Crohn’s Disease Fibrosis

    Friday May 3rd 2024

  • Biotalys starts field trials for second biofungicide

    Thursday May 2nd 2024

Strategic Partners